Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EVO
EVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EVO News
Evotec's Biologics Unit Selected by US Government
Mar 23 2026
Yahoo Finance
Evotec and BMS Initiate Phase 1 Clinical Trial for Kidney Cancer Treatment
Mar 19 2026
Yahoo Finance
Investigation Launched into Evotec SE for Potential Investor Claims
Mar 11 2026
Globenewswire
Evotec Launches Strategic Transformation Initiative 'Horizon'
Mar 10 2026
Benzinga
U.S. Stocks Mixed in Morning Trading
Mar 10 2026
Benzinga
Zevra Therapeutics Reports Strong Q4 Earnings, Shares Surge
Mar 10 2026
Benzinga
DaVita Reports Strong Q4 Earnings, Shares Surge 21.7%
Feb 03 2026
Benzinga
Amgen Acquires Dark Blue Therapeutics for Up to $840 Million
Jan 07 2026
Benzinga
European Market Attracts Dividend Stock Investors Amid 17% Annual Return
Jan 06 2026
Yahoo Finance
NBI Revises EVO ETF Reinvested Distribution to $2.50 per Unit
Jan 05 2026
Yahoo Finance
Top European Dividend Stocks Analysis: Yields Exceeding 5%
Jan 02 2026
Yahoo Finance
Evotec Receives $5M Milestone Payment from Bristol Myers Following FDA Approval of New Drug Application
Nov 12 2025
SeekingAlpha
Evotec SE announces third quarter results
Nov 05 2025
SeekingAlpha
Sandoz to Purchase Just-Evotec Biologics EU SAS in Strategic Move to Expand Biosimilars Portfolio
Nov 05 2025
NASDAQ.COM
ESPR Seeks Diversification Through Rare Liver Disease Candidate, Shares Rise
Oct 17 2025
NASDAQ.COM
Evotec SE (EVO) Q2 2025 Earnings Call Transcript
Aug 13 2025
Newsfilter
Show More News
